A national audit of pancreatic enzyme replacement therapy (PERT) prescribing in patients with pancreatic cancer: The RICOCHET study
This supplement has been commissioned and funded by Viatris and developed in partnership with Guidelines.
NON-2021-4065 February 2022
Appropriate use of opioids for chronic pain in primary care
This promotional supplement has been commissioned and funded by Grünenthal and developed in partnership with Guidelines. Information intended for healthcare professionals only.
View PALEXIA® SR tablets (tapentadol hydrochloride) prescribing and adverse event reporting information
M-PLX-UK-10-21-0036 October 2021
The importance of the progestogenic component of hormone replacement therapy in women with a uterus
Dr John Stevenson and Dr Sophia Tsiligiannis discuss progestogen prescribing in hormone replacement therapy.